Breaking News Instant updates and real-time market news.

NTRA

Natera

$8.16

0.14 (1.75%)

16:34
08/08/17
08/08
16:34
08/08/17
16:34

Natera sees FY17 revenue $210M-$230M, consensus $218.88M

Sees FY17 cost of revenues 60%-65%; selling, general and administrative costs to be approximately $135M-$140M; research and development costs to be $45M-$50M, and net cash burn to be $65M-$75M. Natera's research and development investments are intended to enhance its service offering and reduce the cost of goods sold of Panorama and Horizon, as well as technology development, product development, and clinical trials within oncology.

  • 08

    Aug

  • 21

    Aug

NTRA Natera
$8.16

0.14 (1.75%)

03/08/17
PIPR
03/08/17
NO CHANGE
Target $18
PIPR
Overweight
Piper defends Natera with stock tumbling post earnings
Piper Jaffray analyst William Quirk says he's defending Natera with the stock down 10%-20% in pre-market trading following a "very messy" Q4 and guidance miss. While 2017 will be another transition year, microdel reimbursement and average risk coverage are poised to improve as 2017 progresses, Quirk tells investors in a research note. He continues to believe in Natera's long-term story and keeps an Overweight rating on the name. The analyst cut his price target for the shares to $18 from $20.
03/13/17
BNCH
03/13/17
NO CHANGE
Target $18
BNCH
Buy
Natera weakness a buying opportunity says Benchmark
Benchmark analyst Raymond Myers said multiple factors obscure near-term visibility for Natera, but he recommends using current weakness in the stock as a buying opportunity ahead of "sequentially expanding results" beginning in Q2. He raised his price target on Natera to $18 from $16 and keeps a Buy rating on the stock.
04/18/17
PIPR
04/18/17
NO CHANGE
Target $18
PIPR
Overweight
Piper views Medicaid review as positive for Natera
After reviewing 49 of 50 state Medicaid programs, Piper Jaffray analyst William Quirk says median non-invasive prenatal tests rates for Natera's Panorama are on par with commercial rates while 10 states are now reimbursing for microdeletions. The findings support the company's "burgeoning opportunity" in the Medicaid market, Quirk tells investors in a research note. He keeps an Overweight rating on Natera with an $18 price target.
07/14/17
PIPR
07/14/17
NO CHANGE
Target $18
PIPR
Overweight
Piper views updated Aetna policy as disappointing for Natera
Piper Jaffray analyst William Quirk views Aetna's (AET) updated non-invasive prenatal testing medical policy, where it decided to continue covering the test only in high risk, as "disappointing." Upside for Natera (NTRA) in the second half of 2017 now falls on Medicaid and microdeletion reimbursement progress, and less so commercial payers flipping to cover average risk, Quick tells investors in a research note. He keeps an Overweight rating on Natera shares with an $18 price target.

TODAY'S FREE FLY STORIES

IMPV

Imperva

$45.65

-0.6 (-1.30%)

, FIVN

Five9

$43.21

-1.32 (-2.96%)

09:07
09/24/18
09/24
09:07
09/24/18
09:07
Conference/Events
Microsoft to hold a conferenc e »

Microsoft Ignite will be…

IMPV

Imperva

$45.65

-0.6 (-1.30%)

FIVN

Five9

$43.21

-1.32 (-2.96%)

CDAY

Ceridian

$42.07

-0.855 (-1.99%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 06

    Nov

  • 28

    Nov

  • 03

    Mar

MNKD

MannKind

$1.71

0.02 (1.18%)

09:07
09/24/18
09/24
09:07
09/24/18
09:07
Hot Stocks
MannKind completes cohort 1, opens enrollment of cohort 2 for Afrezza study »

MannKind announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

CZR

Caesars

$10.78

-0.175 (-1.60%)

09:07
09/24/18
09/24
09:07
09/24/18
09:07
Hot Stocks
Caesars names Monica Digilio as Chief Human Resources Officer »

Caesars Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$147.81

-5.105 (-3.34%)

09:06
09/24/18
09/24
09:06
09/24/18
09:06
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$6.46

-0.05 (-0.77%)

, CMCSA

Comcast

$37.91

0.1 (0.26%)

09:05
09/24/18
09/24
09:05
09/24/18
09:05
Periodicals
Tile names GoPro vet CJ Prober CEO, adds Comcast as investor, TechCrunch says »

Tile is appointing CJ…

GPRO

GoPro

$6.46

-0.05 (-0.77%)

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNBX

Cannabics Pharmaceuticals

$0.00

(0.00%)

09:04
09/24/18
09/24
09:04
09/24/18
09:04
Syndicate
Cannabics Pharmaceuticals raises $7.5M in a registered direct offering »

Cannabics Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$107.62

-0.32 (-0.30%)

09:03
09/24/18
09/24
09:03
09/24/18
09:03
Recommendations
Quest Diagnostics analyst commentary  »

Quest Diagnostics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALPMY

Astellas Pharma

$0.00

(0.00%)

, PFE

Pfizer

$44.06

0.3 (0.69%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Hot Stocks
Astellas Pharma receives positive CHMP opinion for Xtandi »

Astellas Pharma announced…

ALPMY

Astellas Pharma

$0.00

(0.00%)

PFE

Pfizer

$44.06

0.3 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 30

    Oct

ALT

Altimmune

$26.03

0.53 (2.08%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Syndicate
Altimmune raises $4.9M in a registered direct offering »

Altimmune announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALT

Altimmune

$26.03

0.53 (2.08%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Syndicate
Altimmune announces $4.9M registered direct offering of common stock »

Altimmune announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$69.05

0.25 (0.36%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Recommendations
Abbott analyst commentary  »

Abbott Mitraclip data a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Hot Stocks
Breaking Hot Stocks news story on Sirius XM »

Sirius XM doesn't…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

PDLI

PDL BioPharma

$2.42

-0.02 (-0.82%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Hot Stocks
PDL BioPharma announces new $100M share repurchase program »

PDL BioPharma announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBEV

New Age Beverages

$6.15

-1.7 (-21.66%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Syndicate
New Age Beverages to offer up to $50M in shares via 'At the Market' offering »

New Age Beverages…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Hot Stocks
Sirius XM says company, Pandora to pay royalties approaching $2B in 2019 »

Sirius XM (SIRI) says…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

RDC

Rowan Companies

$18.02

0.54 (3.09%)

08:59
09/24/18
09/24
08:59
09/24/18
08:59
Upgrade
Rowan Companies rating change  »

Rowan Companies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SEAS

SeaWorld

$30.10

-0.5 (-1.63%)

08:58
09/24/18
09/24
08:58
09/24/18
08:58
Recommendations
SeaWorld analyst commentary  »

SeaWorld price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTRX

Lantronix

$4.14

-0.12 (-2.82%)

08:58
09/24/18
09/24
08:58
09/24/18
08:58
Recommendations
Lantronix analyst commentary  »

Lantronix shares can see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

AAPL

Apple

$217.65

-2.35 (-1.07%)

08:57
09/24/18
09/24
08:57
09/24/18
08:57
Recommendations
Apple analyst commentary  »

Rosenblatt says Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TEUM

Pareteum

$2.80

-0.03 (-1.06%)

08:55
09/24/18
09/24
08:55
09/24/18
08:55
Initiation
Pareteum initiated  »

Pareteum initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTV

Fortive

$86.97

-0.45 (-0.51%)

, AAPL

Apple

$217.65

-2.35 (-1.07%)

08:55
09/24/18
09/24
08:55
09/24/18
08:55
Options
Notable open interest changes for September 24th »

Friday's total…

FTV

Fortive

$86.97

-0.45 (-0.51%)

AAPL

Apple

$217.65

-2.35 (-1.07%)

AMD

AMD

$31.01

-0.17 (-0.55%)

MU

Micron

$44.70

-1.36 (-2.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

, ANDV

Andeavor

$154.80

2.19 (1.44%)

08:55
09/24/18
09/24
08:55
09/24/18
08:55
Conference/Events
Andeavor to host special shareholder meeting »

Special Shareholder…

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

ANDV

Andeavor

$154.80

2.19 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

08:54
09/24/18
09/24
08:54
09/24/18
08:54
Hot Stocks
Breaking Hot Stocks news story on Sirius XM, Pandora, Spotify »

Sirius XM sees taking…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

SPOT

Spotify

$175.06

2.38 (1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

UNFI

United Natural Foods

$31.02

-2.81 (-8.31%)

, SVU

Supervalu

$32.24

0.02 (0.06%)

08:52
09/24/18
09/24
08:52
09/24/18
08:52
Recommendations
United Natural Foods, Supervalu analyst commentary  »

United Natural Foods…

UNFI

United Natural Foods

$31.02

-2.81 (-8.31%)

SVU

Supervalu

$32.24

0.02 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

MU

Micron

$44.70

-1.36 (-2.95%)

, INTC

Intel

$46.64

-0.56 (-1.19%)

08:52
09/24/18
09/24
08:52
09/24/18
08:52
Recommendations
Micron, Intel analyst commentary  »

Micron price target…

MU

Micron

$44.70

-1.36 (-2.95%)

INTC

Intel

$46.64

-0.56 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.